Head-to-head comparisons of medication uses, side effects, warnings, and more.
Envarsus XR is a once-daily version of the common anti-rejection medication, tacrolimus. It's an immunosuppressant that's used to prevent organ rejection in adults after they've had a kidney transplant. Envarsus XR (tacrolimus) is an extended-release tablet that's taken by mouth. Side effects can include risk of infection, diarrhea, and shaky hands. Envarsus XR (tacrolimus) is available as a brand-name medication only; there's currently no generic version yet.
Tacrolimus (Prograf) is a medication used to prevent organ rejection after an organ transplant. The immediate-release (IR) capsules are available as a lower-cost generic medication, whereas the IR granules (Prograf) and extended-release (ER) capsules (Astagraf XL) are only available as brand-name medications. Tacrolimus (Prograf) is taken by mouth, typically twice daily. Your provider will check your tacrolimus level through blood work and adjust your dose if needed. Common side effects of tacrolimus (Prograf) include tremors, headache, diarrhea, and nausea.
Prevention of organ transplant rejection, including:
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.